Discussion about this post

User's avatar
Paul Beighley's avatar

Except … tens of millions of us do not hesitate to take longevity drugs every day. These include statins, antihypertensives, etc.

My issue is with “longevity drugs” which have marginal in vitro evidence of efficacy and which rely on biomarkers rather than evidence of actual in vivo benefit. And which may have profound harm. Mind you, I have some questions regarding drugs such as statins when number needed to treat versus number needed to harm data is considered.

Expand full comment
3 more comments...

No posts